Andrea Brettler

Andrea Brettler is an Analyst at Samlyn Capital, LLC, a New York-based hedge fund, where she leverages her deep expertise in the biotechnology and healthcare investment sectors. In her current role, Brettler focuses on public equities, particularly within biotech, applying analytical rigor to evaluate and identify high-potential investment opportunities in the life sciences industry.

Previously, Brettler held the positions of Director and Associate Director at Tang Capital Management, a firm renowned for its concentration in healthcare and biotech investments, where she furthered her sector specialization and deal execution skills. Her earlier career experience includes roles at UBS Securities and Retrophin, giving her a robust foundation in equity research and health technology finance.

Andrea Brettler holds a graduate degree from Columbia University and an undergraduate degree from Harvard University, reflecting strong academic credentials in finance and analysis. She is recognized for her analytical acumen, sector expertise, and significant contributions to investment research and capital allocation within the healthcare and biotechnology asset classes.